glp-1 drugs and thyroid cancer Increased screening may lead to higher risk after initiation Study Assuages Thyroid Cancer Fears

Medical Research Archives, [online] 12(10)

That said, these effects are only observed when the medication is prescribed appropriately and used in combination with provider-guided lifestyle support

This data gap means we cannot quantify infant exposure or confirm safety, making the conservative medical approach to avoid these medications during breastfeeding

Another review looked at how well different GLP-1 receptor agonists worked when added to metformin in people with type 2 diabetes

For example, in the context of vascular anti-inflammatory response pertaining to atherosclerosis, GLP-1RA liraglutide was found to inhibit human plasminogen activator inhibitor type-1 secondary to tumor necrosis factor alpha (TNF-alpha) signaling [45]

Recent advances in dipeptidyl-peptidase-4 inhibition therapy: lessons from the bench and clinical trials